The BC subtypes are commonly grouped into four categories based on the immunohistochemical expression of hormone receptors: estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), and human epidermal growth factor receptor-positive (HER-II+). This evidence concerns the gene PGR and breast cancer.